Effect of Pharmacist Management on Serum Hemoglobin Levels with Renal Anemia in Hemodialysis Outpatients

A, Miyake; Kuwatsuka, Keiko; Onoue, Yuka; Lee, Miyoshi; Koyama, Toshihiro; Sendo, Toshiaki; Kawasaki, Hiromu; Kitamura, Yoshihisa

doi:10.1248/bpb.34.1609

Cited by 16 publications

(37 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results of this study were in agreement with previously published studies . A historical cohort study was conducted to compare the role of pharmacist‐managed erythropoietin‐stimulating agents (ESA) clinics with usual care at an ESA clinic site and at a usual‐care site.…”

Section: Discussionsupporting

confidence: 88%

“…The results showed significant improvement in Hgb values according to hospital guidelines. The study concluded that the introduction of pharmaceutical care services in patients undergoing haemodialysis improved healthcare outcomes …”

Section: Discussionmentioning

confidence: 99%

“…The results of this study were in agreement with previously published studies. [26,27] A historical cohort study was conducted to compare the role of pharmacist-managed erythropoietin-stimulating agents (ESA) clinics with usual care at an ESA clinic site and at a usual-care site. Primary outcomes included the proportion of haemoglobin values at goal, the dose of ESA and Hgb monitoring frequency.…”

Section: Discussionmentioning

confidence: 99%

“…The study concluded that the introduction of pharmaceutical care services in patients undergoing haemodialysis improved healthcare outcomes. 27 The improvement in intervention group patients could be related to number of interventions: for example patient counselling, which was conducted privately, face to face and in simple layman's language. Patients were provided with a pamphlet to simplify educational material and to help them remember instructions.…”

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

A randomised control trial to evaluate the clinical pharmacist's role in managing iron deficiency anaemia patients

Tahaineh

Khasawneh

2017

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

Objective To investigate the role of clinical pharmacists in managing iron deficiency anaemia patients. Methods A prospective parallel randomised controlled trial conducted in an outpatient clinic enrolled adult iron deficiency anaemia patients. Patients were randomised into either an intervention or a control group. Patients in the intervention group were followed closely by a clinical pharmacist who offered pharmaceutical care services and worked closely with physicians to manage iron deficiency anaemia. Patients in the control group received the usual medical care.

show abstract

Section: Discussionsupporting

confidence: 88%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

A randomised control trial to evaluate the clinical pharmacist's role in managing iron deficiency anaemia patients

Tahaineh

Khasawneh

2017

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

show abstract

“…They also found that patients of ethnic-minority background reported less out-ofoffice communication with their family doctors. A number of studies looked at provider-provider relations, most often the collaboration between pharmacists and physicians (Niquille, Lattmann, & Bugnon, 2010;Ohnishi et al, 2011). In one study that included patient outcomes, Anaya et al (2008) found that collaborative drug-therapy agreements among physicians, patients, and pharmacists in diabetes-mellitus management led to better blood glucose control.…”

Section: Introductionmentioning

confidence: 99%

Exploring Interpersonal Relationships in a Nurse-Managed Clinic and Their Impact on Clinical Outcomes

et al. 2019

View full text Add to dashboard Cite

This study explores the impact of interpersonal relationships on processes and outcomes of care at a nurse-managed, primary care clinic in Southern California serving a vulnerable population. Ten semistructured interviews were conducted with all health care providers in the clinic to explore patient characteristics, types of relationships experienced, and how they may have affected processes and outcomes of care. Themes in interviews were identified through thematic analysis. We found that (a) patients with limited access to health care and resources establish different types of relationships to support their needs, and (b) interpersonal relationships, including those among providers, affect quality of care.

show abstract

A pharmacist‐managed dosing algorithm for darbepoetin alfa and iron sucrose in hemodialysis patients: A randomized, controlled trial

Oever

Heetman-Meijer

Birnie

et al. 2020

Pharmacology Res & Perspec

View full text Add to dashboard Cite

The attainment of target hemoglobin levels in hemodialysis patients is low. Several factors play a role, such as hyporesponsiveness to erythropoiesis‐stimulating agents (ESA), but also suboptimal prescribing of ESA and iron. The goal of this study was to investigate if a pharmacist‐managed dosing algorithm for darbepoetin alfa (DA) and iron sucrose improves the attainment of target hemoglobin levels. In this randomized controlled trial, 200 hemodialysis patients from a Dutch teaching hospital were included. In the intervention group (n = 100), a pharmacist monthly provided dose recommendations for DA and iron sucrose based on dosing algorithms. The control group (n = 100) received usual care. In the intervention group, the percentage per patient within the target range (PTR) for hemoglobin (target range 6.8‐7.4 mmol/L) and iron status was higher than in the control group (for hemoglobin median 38.5% vs 23.1%, P = .001 and for iron status median 21.1% vs 8.3%, P = .003). The percentage of high hemoglobin levels (>8.1 mmol/L) was lower in the intervention group (median 0.0% vs 7.7%, P = .034). The weekly dose of DA was lower in the intervention group (median 34.0 vs 46.9 mcg, P = .020), whereas iron dose was higher (median 75 vs 0 mg). No difference was found for the percentage of hemoglobin levels below the target range. In conclusion, a pharmacist‐managed dosing algorithm for DA and iron sucrose increased the attainment of target levels for hemoglobin and iron status, reduced the percentage of high hemoglobin levels, and was associated with a lower DA and a higher iron sucrose dose.

show abstract

Effect of Pharmacist Management on Serum Hemoglobin Levels with Renal Anemia in Hemodialysis Outpatients

Abstract: It is hoped that the clinical activities of pharmacists will enhance the quality of drug therapy. The anemia of chronic renal failure is usually characterized as a normocytic, normochromic form occurring in end-stage renal disease.

Cited by 16 publications

References 13 publications

A randomised control trial to evaluate the clinical pharmacist's role in managing iron deficiency anaemia patients

A randomised control trial to evaluate the clinical pharmacist's role in managing iron deficiency anaemia patients

Exploring Interpersonal Relationships in a Nurse-Managed Clinic and Their Impact on Clinical Outcomes

A pharmacist‐managed dosing algorithm for darbepoetin alfa and iron sucrose in hemodialysis patients: A randomized, controlled trial

Contact Info

Product

Resources

About